We are updating our Privacy Policy and Terms and Conditions to help you clearly understand how your personal information is collected, stored and managed. Learn More
Menu Back toArtificial-Intelligence-The-Future-of-Regulatory-Affairs

DIA 2018 Global Annual Meeting

The DIA 2018 Global Annual Meeting brings together thousands of innovators from around the globe.

Artificial Intelligence: The Future of Regulatory Affairs

    Session Chair(s)
      Linda  Bowen, MSc, RAC

      Linda Bowen, MSc, RAC

      • Assistant Professor
      • Temple University, United States
    This session will focus on the various aspects of artificial intelligence (AI) currently incorporated in regulatory processes as well a futuristic look at what it can do for the RA function. Case studies and lessons learned on AI pilots within the biopharma and medical device industry will be highlighted as well as FDA's perspective on the future of AI.
    Learning Objective : Formulate a strategy for a future regulatory affairs function that leverages the use of advanced technologies Design a holistic regulatory information management operating model (governance, people, process, and traditional and advanced technology)
      Oliver  Steck

      Regulatory 2.0: The Future of Regulatory Affairs and Advanced Technologies

      Oliver Steck

      • Principal
      • Deloitte & Touche LLP, United States
      Dany  De Grave

      Exploring New Ways of Working Using Artificial Intelligence: Proof of Concept Pilot

      Dany De Grave

      • Senior Director, Innovation Programs & External Networks
      • Sanofi Pasteur, United States
      Bakul  Patel, MD

      FDA Update

      Bakul Patel, MD

      • Associate Director for Digital Health, Office of the Center Director, CDRH
      • FDA, United States